Jay S. Schneider, PhD
Professor
Contact
1020 Locust Street
Jefferson Alumni Hall, Suite 521
Philadelphia, PA 19107
Jay S. Schneider, PhD
Professor
Research & Clinical Interests
Basic, clinical and translational research on cognitive and motor aspects of Parkinson's disease with focuses on both symptomatic and neuroprotective treatment strategies; basic and clinical research on developmental neurotoxicology with an emphasis on lead-induced damage to the brain.
Education
PhD, State University of New York at Stony Brook (1981)
Most Recent Peer-Reviewed Publications
- Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent?
- GM1 Ganglioside as a Disease-Modifying Therapeutic for Parkinson’s Disease: A Multi-Functional Glycosphingolipid That Targets Multiple Parkinson’s Disease-Relevant Pathogenic Mechanisms
- Altered genome-wide hippocampal gene expression profiles following early life lead exposure and their potential for reversal by environmental enrichment
- Altered expression of glycobiology-related genes in Parkinson’s disease brain
- GM1 ganglioside modifies microglial and neuroinflammatory responses to α-synuclein in the rat AAV-A53T α-synuclein model of Parkinson's disease